Skip to content

Comparison the effect of Sucrose gel with Metronidazole gel in the treatment of bacterial vaginosis

Comparison the effect of Sucrose gel with Metronidazole gel in the treatment of women with bacterial vaginosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016112631105N1
Enrollment
70
Registered
2016-12-27
Start date
2012-03-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial vaginosis. Other specified inflammation of vagina and vulva

Interventions

Intervention 1: The samples used a 70-gram tube from Sucrose gel in 5 days. Intervention 2: The samples used a 70-gram tube from Metronidazole gel in 5 days.
Treatment - Drugs
The samples used a 70-gram tube from Sucrose gel in 5 days.
The samples used a 70-gram tube from Metronidazole gel in 5 days.

Sponsors

Vice chancellor for Research and Technology, Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Married women of reproductive age (15 to 45 years old); Positive Gram staining of bacterial vaginosis; Bacterial vaginosis symptoms on clinical examination; Non-current use of anti-parasitic drugs, antibiotics, immunosuppressive drugs and vaginal medications during the past two weeks; Lack of abnormal uterine bleeding; Not having recurrent vaginitis (4 or more than 4 times a year); No pregnancy; No breastfeeding; No use douching frequently; No alcohol and anticoagulant coumarin; No cases of multiple sex partners; No getting certain diseases, such as liver disease, diseases of the central nervous system, blood Dyscrasia, diabetes, immune deficiency; No history of allergy to mint category and garlic taken orally or topically. Exclusion criteria: Sensitivity to the drug and non-drug use; taking any prescribed medications with conflicting effect with medicines in this study; taking any drug that affect vaginosis symptoms and treatment; lack of patients interest

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Vaginal discharge. Timepoint: Before the intervention, two weeks after intervention. Method of measurement: Observation.;Wiff test. Timepoint: Before the intervention, two weeks after intervention. Method of measurement: Potassium hydroxide solution 10%.;Number key cells. Timepoint: Before the intervention, two weeks after intervention. Method of measurement: Gram stain.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdiye Donyadari

Zahedan University of Medical Sciences

m_20282000@yahoo.com+98 54 3343 8473

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 23, 2026